GILD Gilead Sciences, Inc.

Healthcare

Price

$144.23

Intrinsic value

$63.56

Buy price

$50.85

Discount

-126.9%

Overvalued [LOW CF reliability]

Live signals (1)

Daily bars as of Oct 8, 2026

UCUptrend ContinuationBullish ↑
A strong bullish bar closing back into a rising 20/50-SMA stack - the uptrend resuming after a pullback to the moving averages.
Fired Oct 8, 2026on the latest daily bar35.8% win rate · 1x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)2.57%

Terminal growth (g2)3.50%

Years of g1 growth4

Discount rate9.00%

Margin of safety20.00%

Operating CF: $13,552,000,000.00
Total debt: $26,246,000,640.00
Cash & STI: $4,881,999,872.00
Shares out.: 1,243,000,000

Overvalued [LOW CF reliability]

Intrinsic value$63.57

Buy price (with MOS)$50.86

Current price$144.23

Discount to intrinsic value-126.9%

7-step quality scorecard

ROE quality

HIGH_VOLATILE

Average ROE: 21.6%
Current ROE: 37.5%
Minimum ROE: 2.5%

Debt quality

LEVERAGED

Debt / Equity: 1.16x

Moat proxy

MODERATE_PROXY

Cash-flow reliability

LOW

Operating CF / Net income: —

Technical chart

Confluence: NONE (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source: yfinance
Growth (g1) source: min(revenueCAGR,cfCAGR)
Valuation model: DCF_OCF
Debt as % of DCF PV: 26.2%
Public economic interest: 100.4%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.